FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
+11.73%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$239M
AUM Growth
+$239M
(+18%)
Cap. Flow
+$20.4M
Cap. Flow
% of AUM
8.54%
Top 10 Holdings %
Top 10 Hldgs %
46.71%
Holding
69
New
7
Increased
14
Reduced
22
Closed
4
Top Buys
| 1 |
AMED
Amedisys
AMED
|
$5.75M |
| 2 |
ELGX
Endologix Inc
ELGX
|
$5.17M |
| 3 |
LDRH
LDR HOLDINGS CORP COM STK
LDRH
|
$4.45M |
| 4 |
MDVN
MEDIVATION, INC.
MDVN
|
$4.05M |
| 5 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
$3.46M |
Top Sells
| 1 |
Omnicell
OMCL
|
$5.36M |
| 2 |
SRGA
Surgalign Holdings, Inc. Common Stock
SRGA
|
$3.93M |
| 3 |
Bio-Techne
TECH
|
$2.68M |
| 4 |
ARRY
Array Biopharma Inc
ARRY
|
$1.93M |
| 5 |
Esperion Therapeutics
ESPR
|
$1.13M |
Sector Composition
| 1 | Healthcare | 77.26% |
| 2 | Energy | 3.08% |
| 3 | Real Estate | 2.24% |
| 4 | Financials | 0.24% |
| 5 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
NeoGenomics
NEO
$1.13B
| $24.3M | 10.18% | 3,089,881 +118,336 | +4% | +$931K |
|
2
AtriCure
ATRC
$1.84B
| $20.7M | 8.67% | 922,557 +23,195 | +3% | +$520K |
|
|
AKRX
3
DELISTED
Akorn, Inc.
AKRX
| $12.7M | 5.34% | 341,453 +16,973 | +5% | +$633K |
|
|
ENZ
4
DELISTED
Enzo Biochem, Inc.
ENZ
| $10.3M | 4.31% | 2,288,292 +62,291 | +3% | +$280K |
|
|
TLGT
5
DELISTED
Teligent, Inc
TLGT
| $8.89M | 3.72% | 998,610 -12,607 | -1% | -$112K |
|
|
LHCG
6
DELISTED
LHC Group LLC
LHCG
| $7.35M | 3.08% | 162,188 +9,747 | +6% | +$441K |
|
7
Harvard Bioscience
HBIO
$22M
| $7.08M | 2.96% | 2,039,753 +57,559 | +3% | +$200K |
|
|
ELGX
8
DELISTED
Endologix Inc
ELGX
| $6.96M | 2.91% | 702,824 +521,861 | +288% | +$5.17M |
|
|
ENTL
9
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
| $6.6M | 2.76% | 391,497 +148,965 | +61% | +$2.51M |
|
10
LeMaitre Vascular
LMAT
$2.16B
| $6.59M | 2.76% | 381,849 +5,638 | +1% | +$97.3K |
|
11
Ligand Pharmaceuticals
LGND
$3.15B
| $6.16M | 2.58% | 56,818 -753 | -1% | -$81.6K |
|
|
OXFD
12
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $5.76M | 2.41% | 500,697 -20,058 | -4% | -$231K |
|
|
AMED
13
DELISTED
Amedisys
AMED
| $5.75M | 2.41% | +146,287 | New | +$5.75M |
|
|
NXTM
14
DELISTED
NxStage Medical Inc.
NXTM
| $5.5M | 2.3% | 251,093 +10,864 | +5% | +$238K |
|
|
DOC
15
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $5.36M | 2.24% | 317,817 -4,162 | -1% | -$70.2K |
|
|
TEAR
16
DELISTED
TearLab Corporation
TEAR
| $5.23M | 2.19% | 3,761,436 -2,729 | -0.1% | -$3.79K |
|
17
Alkermes
ALKS
$4.78B
| $5.04M | 2.11% | 63,484 -664 | -1% | -$52.7K |
|
18
Insmed
INSM
$28.8B
| $4.58M | 1.92% | 252,495 -19,898 | -7% | -$361K |
|
|
CYNA
19
DELISTED
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
| $4.53M | 1.9% | 296,072 -6,122 | -2% | -$93.6K |
|
|
LDRH
20
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
| $4.45M | 1.86% | +177,065 | New | +$4.45M |
|
|
BLUE
21
DELISTED
bluebird bio
BLUE
| $4.25M | 1.78% | 66,104 +52,481 | +385% | +$3.37M |
|
22
QuidelOrtho
QDEL
$1.95B
| $4.14M | 1.73% | 195,243 -5,824 | -3% | -$123K |
|
|
MDVN
23
DELISTED
MEDIVATION, INC.
MDVN
| $4.05M | 1.7% | +83,816 | New | +$4.05M |
|
|
SPNC
24
DELISTED
Spectranetics Corp
SPNC
| $4M | 1.68% | 265,762 -19,834 | -7% | -$299K |
|
|
SRGA
25
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $3.99M | 1.67% | 1,005,889 -990,302 | -50% | -$3.93M |
|